doi: 10.1128/AAC.31.3.455.
In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria
- PMID: 3034145
- PMCID: PMC174751
- DOI: 10.1128/AAC.31.3.455
Item in Clipboard
In vitro activity of a new cyclic lipopeptide antibiotic, LY146032, against gram-positive clinical bacteria
Antimicrob Agents Chemother.
1987 Mar.
Abstract
The in vitro activity of LY146032, a novel cyclic lipopeptide antibiotic, was tested against different gram-positive clinical isolates. The activity of LY146032 was clearly higher than that of vancomycin against all isolates tested. However, in some instances rifampin and imipenem showed higher activity than did LY146032.
Similar articles
-
Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.Eur J Clin Microbiol. 1987 Feb;6(1):100-3. doi: 10.1007/BF02097211. Eur J Clin Microbiol. 1987. PMID: 3032607
-
In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria.Antimicrob Agents Chemother. 1988 Feb;32(2):279-81. doi: 10.1128/AAC.32.2.279. Antimicrob Agents Chemother. 1988. PMID: 2834999 Free PMC article.
-
Comparative in-vitro activity of LY146032 a new peptolide, with vancomycin and eight other agents against gram-positive organisms.J Antimicrob Chemother. 1987 Aug;20(2):191-6. doi: 10.1093/jac/20.2.191. J Antimicrob Chemother. 1987. PMID: 2822645
-
[Daptomycin, the first cydal antibiotic of a new class active against Gram positive pathogens].Infez Med. 2006 Dec;14(4):179-96. Infez Med. 2006. PMID: 17380085 Review. Italian.
-
Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.J Antimicrob Chemother. 2005 Mar;55(3):283-8. doi: 10.1093/jac/dkh546. Epub 2005 Feb 10. J Antimicrob Chemother. 2005. PMID: 15705644 Review.
Cited by
-
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.Antimicrob Agents Chemother. 2003 Jan;47(1):337-41. doi: 10.1128/AAC.47.1.337-341.2003. Antimicrob Agents Chemother. 2003. PMID: 12499210 Free PMC article.
-
In vitro activity of daptomycin-metronidazole combinations against mixed bacterial cultures: reduced activity of metronidazole against Bacteroides species in the presence of Enterococcus faecalis.Eur J Clin Microbiol Infect Dis. 1990 Apr;9(4):287-91. doi: 10.1007/BF01968064. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2161762
-
Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032).Antimicrob Agents Chemother. 1990 Jun;34(6):1220-6. doi: 10.1128/AAC.34.6.1220. Antimicrob Agents Chemother. 1990. PMID: 2168145 Free PMC article.
-
Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model.Antimicrob Agents Chemother. 1992 Oct;36(10):2334-7. doi: 10.1128/AAC.36.10.2334. Antimicrob Agents Chemother. 1992. PMID: 1332596 Free PMC article.
-
Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits.Antimicrob Agents Chemother. 1990 Feb;34(2):245-51. doi: 10.1128/AAC.34.2.245. Antimicrob Agents Chemother. 1990. PMID: 2158276 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
